Clinician Summary – Aug. 31, 2016
Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence
Formats
- View PDF(PDF) 269 kB
- Help with Viewers, Players, and Plug-ins
Table of Contents
- Focus of This Summary
- Background
- Conclusions
- Overview of Clinical Research Evidence
- Other Findings of the Review
- Gaps in Knowledge and Limitations of the Evidence Base
- What To Discuss With Parents and Caregivers of Children with DBDs
- Source
Focus of This Summary
This is a summary of a systematic review evaluating the evidence regarding the potential benefits and adverse effects of psychosocial and pharmacologic treatment approaches for children and adolescents with disruptive behavior disorders (DBDs). The systematic review included 84 unique studies published from 1994 to June 2014. This summary is provided to assist in informed clinical decisionmaking. However, reviews of evidence should not be construed to represent clinical recommendations or guidelines.
Background
Disruptive behavior disorders (DBDs) are a group of related psychiatric disorders of childhood and adolescence and include conduct disorder, intermittent explosive disorder, or oppositional defiant disorder. Children with DBDs may be aggressive and defiant and may struggle to get along with peers, family members, or authority figures. However, symptoms vary significantly between children and over time. Children with DBDs may be at greater risk for problems in adolescence and later in life, such as substance abuse, delinquency, or criminal behavior. DBDs are diagnosed in approximately 3 percent of children in the United States.
.png)
No hay comentarios:
Publicar un comentario